Gabapentinoids are effective in decreasing neuropathic pain and other secondary outcomes after spinal cord injury: a meta-analysis
- PMID: 24992021
- DOI: 10.1016/j.apmr.2014.06.010
Gabapentinoids are effective in decreasing neuropathic pain and other secondary outcomes after spinal cord injury: a meta-analysis
Abstract
Objective: To examine the effectiveness of gabapentin and pregabalin in diminishing neuropathic pain and other secondary conditions in individuals with spinal cord injury (SCI).
Data sources: A systematic search was conducted using multiple databases for relevant articles published from 1980 to June 2013.
Study selection: Controlled and uncontrolled trials involving gabapentin and pregabalin for treatment of neuropathic pain, with ≥3 subjects and ≥50% of study population with SCI, were included.
Data extraction: Two independent reviewers selected studies based on inclusion criteria and then extracted data. Pooled analysis using Cohen's d to calculate standardized mean difference (SMD), SE, and 95% confidence interval (CI) for primary (pain) and secondary outcomes (anxiety, depression, sleep interference) was conducted.
Data synthesis: Eight studies met inclusion criteria. There was a significant reduction in the intensity of neuropathic pain at <3 months (SMD=.96±.11; 95% CI, .74-1.19; P<.001) and between 3 and 6 months (SMD=2.80±.18; 95% CI, 2.44-3.16; P<.001). A subanalysis found a significant decrease in pain with gabapentin (SMD=1.20±.16; 95% CI, .88-1.52; P<.001) and with pregabalin (SMD=1.71±.13; 95% CI, 1.458-1.965; P<.001). A significant reduction in other SCI secondary conditions, including sleep interference (SMD=1.46±.12; 95% CI, 1.22-1.71; P<.001), anxiety (SMD=1.05±.12; 95% CI, .81-1.29; P<.001), and depression (SMD=1.22±.13; 95% CI, .967-1.481; P<.001) symptoms, was shown. A significantly higher risk of dizziness (risk ratio [RR]=2.02, P=.02), edema (RR=6.140, P=.04), and somnolence (RR=1.75, P=.01) was observed.
Conclusions: Gabapentin and pregabalin appear useful for treating pain and other secondary conditions after SCI. Effectiveness comparative to other analgesics has not been studied. Patients need to be monitored closely for side effects.
Keywords: Pain; Rehabilitation; Spinal cord injuries.
Copyright © 2014 American Congress of Rehabilitation Medicine. Published by Elsevier Inc. All rights reserved.
Similar articles
-
Efficacy and safety of gabapentin 1800 mg treatment for post-herpetic neuralgia: a meta-analysis of randomized controlled trials.J Clin Pharm Ther. 2014 Aug;39(4):334-42. doi: 10.1111/jcpt.12167. Epub 2014 May 8. J Clin Pharm Ther. 2014. PMID: 24806220 Review.
-
Gabapentin effect on neuropathic pain compared among patients with spinal cord injury and different durations of symptoms.Spine (Phila Pa 1976). 2003 Feb 15;28(4):341-6; discussion 346-7. doi: 10.1097/01.BRS.0000048464.57011.00. Spine (Phila Pa 1976). 2003. PMID: 12590206 Clinical Trial.
-
Pregabalin in neuropathic pain: a more "pharmaceutically elegant" gabapentin?Am J Geriatr Pharmacother. 2005 Dec;3(4):274-87. Am J Geriatr Pharmacother. 2005. PMID: 16503325 Review.
-
Pregabalin versus gabapentin in the treatment of neuropathic pruritus in maintenance haemodialysis patients: a prospective, crossover study.Nephrology (Carlton). 2012 Nov;17(8):710-7. doi: 10.1111/j.1440-1797.2012.01655.x. Nephrology (Carlton). 2012. PMID: 22909343 Clinical Trial.
-
Comparison of the effectiveness of amitriptyline and gabapentin on chronic neuropathic pain in persons with spinal cord injury.Arch Phys Med Rehabil. 2007 Dec;88(12):1547-60. doi: 10.1016/j.apmr.2007.07.038. Arch Phys Med Rehabil. 2007. PMID: 18047869 Clinical Trial.
Cited by
-
Repeated Sigma-1 Receptor Antagonist MR309 Administration Modulates Central Neuropathic Pain Development After Spinal Cord Injury in Mice.Front Pharmacol. 2019 Mar 22;10:222. doi: 10.3389/fphar.2019.00222. eCollection 2019. Front Pharmacol. 2019. PMID: 30967775 Free PMC article.
-
Pain relief and functional improvement in patients with neuropathic pain associated with spinal cord injury: an exploratory analysis of pregabalin clinical trials.J Pain Res. 2016 Jun 15;9:405-16. doi: 10.2147/JPR.S97770. eCollection 2016. J Pain Res. 2016. PMID: 27366103 Free PMC article.
-
Misuse of gabapentinoids (pregabalin and gabapentin) in patients with neuropathic pain related to spinal cord injury.J Spinal Cord Med. 2023 Sep;46(5):859-864. doi: 10.1080/10790268.2021.2024709. Epub 2022 Feb 2. J Spinal Cord Med. 2023. PMID: 35108174 Free PMC article.
-
Utilization of medicinal cannabis for pain by individuals with spinal cord injury.Spinal Cord Ser Cases. 2019 Jul 10;5:66. doi: 10.1038/s41394-019-0208-6. eCollection 2019. Spinal Cord Ser Cases. 2019. PMID: 31632724 Free PMC article.
-
The CanPain SCI clinical practice guidelines for rehabilitation management of neuropathic pain after spinal cord injury: 2021 update.Spinal Cord. 2022 Jun;60(6):548-566. doi: 10.1038/s41393-021-00744-z. Epub 2022 Feb 5. Spinal Cord. 2022. PMID: 35124700 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous